Capital deployed:

£600,000 SEIS & EIS qualifying

Use of funds:
  • Establish team & facilities
  • Further develop lead assets
  • Progress pre-clinical programmes

Capital deployed:

£600,000 SEIS & EIS qualifying

Use of funds:
  • Establish team & facilities
  • Further develop lead assets
  • Progress pre-clinical programmes
Founded in 2022 as a spin out from the University of Dundee, Glen Clova Scientific is developing a new generation of active biologic drugs for chronic inflammatory and autoimmune disorders. This initial seed funding round of £2.5m enables the Company to advance the preclinical development of its three initial drug candidates – for the treatments of senile pruritus, atopic dermatitis and eczema.
 
DSW Ventures participated alongside Norcliffe Capital, TriCapital Angels and Scottish Enterprise in a combined SEIS and EIS investment.
Scroll to Top